Global Anti-Hypertensive Drugs Market Outlook 2022

The global Anti-Hypertensive Drugs market was valued at US$ 39740 million in 2020 and is expected to reach US$ 46250 million by the end of 2027, growing at a CAGR of 2.5% during 2021-2027.
This report focuses on Anti-Hypertensive Drugs volume and value at the global level, regional level and company level. From a global perspective, this report represents overall Anti-Hypertensive Drugs market size by analysing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, Asia-Pacific, Latin America and Middle East & Africa.

Global Anti-Hypertensive Drugs Market: Segment Analysis
The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2016 to 2027. Understanding the segments helps in identifying the importance of different factors that aid the market growth.


Segment by Type
Diuretics
Angiotensin Converting Enzyme (ACE) Inhibitors
Angiotensin Receptor Blockers (ARBs)
Calcium Channel Blockers
Beta Blockers
Alpha Blockers
Vasodilators
Renin Inhibitors


Segment by Application
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies


By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E


By Company
Novartis
Pfizer
Johnson & Johnson
Sanofi
Lupin
Ranbaxy Laboratories
Merck
AstraZeneca
Daiichi Sankyo Company Limited
Takeda Pharmaceutical